Table 2.
Cervical cancer screening history | Participants from cancer registries N = 480 | Participants from survivor social network N = 148 | P-value* |
---|---|---|---|
n (%) | n (%) | ||
Received any cervical cancer screening 5 years prior to cervical cancer diagnosisa | |||
Yes | 223 (50%) | 115 (79%) | <.001 |
No | 219 (50%) | 31 (21%) | |
When first diagnosed with invasive cervical cancer | |||
Part of routine exams/screening (not because of symptoms) | 177 (37%) | 60 (41%) | .550 |
Seeking medical care for problems/symptoms | 251 (53%) | 71 (48%) | |
Other | 46 (10%) | 17 (11%) | |
Follow-up of abnormal Pap or HPV test in 5 years prior to diagnosis | |||
Follow-up of results as recommended by doctor | 168 (37%) | 43 (33%) | .506 |
Follow-up of results, but waited longer than recommended | 34 (8%) | 11 (8%) | |
No, did not follow-up | 32 (7%) | 6 (5%) | |
Didn’t have an abnormal Pap or HPV test or never had Pap/HPV test | 218 (48%) | 71 (54%) |
Participants were asked to exclude the screening test that led to cervical cancer diagnosis.
Significance was tested with Pearson chi-square when there were 5 or more cases in each cell; Fisher’s exact test when any cell had <5 cases.